Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1048 of 1,261
  1. US 7446185

    Her2/neu target antigen and use of same to stimulate an immune response

    The Regents of the University of California · Granted Nov 4, 2008 · Expires Oct 30, 2028

    granted
  2. US 7445794

    Methods for treating human proliferative diseases, with a combination of fatty acid metabolism inhibitors and glycolytic inhibitors

    The Regents of the University of Colorado · Granted Nov 4, 2008 · Expires Oct 30, 2028

    granted
  3. US 7442558

    Phthalamide-lanthanide complexes for use as luminescent markers

    The Regents of the University of California · Granted Oct 28, 2008 · Expires Oct 23, 2028

    granted
  4. US 7442718

    Inhibitors of aspartyl protease

    Vertex Pharmaceuticals Incorporated · Granted Oct 28, 2008 · Expires Oct 23, 2028

    granted
  5. US 7442790

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Oct 28, 2008 · Expires Oct 23, 2028

    granted
  6. US 7442696

    Mineralocorticoid receptor modulator compounds, processes for their preparation, and their uses

    Ligand Pharmaceuticals Incorporated · Granted Oct 28, 2008 · Expires Oct 23, 2028

    granted
  7. US 7442806

    Processes for preparing darifenacin hydrobromide

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Oct 28, 2008 · Expires Oct 23, 2028

    granted
  8. US 7442372

    Delivery of therapeutic compounds to the brain and other tissues

    BIOMARIN PHARMACEUTICAL INC. · Granted Oct 28, 2008 · Expires Oct 23, 2028

    granted
  9. US 7442546

    Method of modulating inflammatory response

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Oct 28, 2008 · Expires Oct 23, 2028

    granted
  10. US 7442543

    Mammalian selenoprotein differentially expressed in tumor cells

    The United States of America, as represented by the Department of Health and Human Services · Granted Oct 28, 2008 · Expires Oct 23, 2028

    granted
  11. US 7442391

    Bioactive botanical cosmetic compositions and processes for their production

    INTEGRATED BOTANICAL TECHNOLOGIES, LLC · Granted Oct 28, 2008 · Expires Oct 23, 2028

    granted
  12. US 7439252

    Ascomycin crystalline forms and preparation thereof

    TEVA Gyógyszergyár Zártkörüen Müködö Részvénytárasaság · Granted Oct 21, 2008 · Expires Oct 16, 2028

    granted
  13. US 7439226

    Serine protease inhibitors

    The United States of America, as represented by the Department of Health and Human Services · Granted Oct 21, 2008 · Expires Oct 16, 2028

    granted
  14. US 7438915

    Immunopotentiating effect of a Fomitella fraxinea-derived lectin on chicken immunity and resistance to coccidiosis

    The United States of America, as represented by the Secretary of Agriculture · Granted Oct 21, 2008 · Expires Oct 16, 2028

    granted
  15. US 7439249

    Inhibitors of phosphatases

    Vertex Pharmaceuticals Incorporated · Granted Oct 21, 2008 · Expires Oct 16, 2028

    granted
  16. US 7439265

    Irciniastatins a and b

    ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Oct 21, 2008 · Expires Oct 16, 2028

    granted
  17. US 7439373

    Crystalline mycophenolate sodium

    TEVA Gyógyszergyár Zártkörüen Müködö Részvénytárasaság · Granted Oct 21, 2008 · Expires Oct 16, 2028

    granted
  18. US 7439398

    Enantiomerically pure atomoxetine and tomoxetine mandelate

    Teva Pharmaceutical Fine Chemicals S.R.L. · Granted Oct 21, 2008 · Expires Oct 16, 2028

    granted
  19. US 7439399

    Processes for the preparation of atomoxetine hydrochloride

    Teva Pharmaceutical Fine Chemicals S.R.L. · Granted Oct 21, 2008 · Expires Oct 16, 2028

    granted
  20. US 7439231

    Inhibitors of antigen presentation by MHC class II molecules and methods of use thereof

    Provid Pharmaceuticals Inc. · Granted Oct 21, 2008 · Expires Oct 16, 2028

    granted
  21. US 7439013

    Biocompatible polymer and filter for selectively eliminating leucocytes using the same

    ASAHI KASEI KURARAY MEDICAL CO., LTD. · Granted Oct 21, 2008 · Expires Oct 16, 2028

    granted
  22. US 7439323

    Cysteine-containing peptides having antioxidant properties

    The Regents of the University of California · Granted Oct 21, 2008 · Expires Oct 16, 2028

    granted
  23. US 7439045

    pH controlled fermentation process for pseudomonic acid production

    TEVA Gyógyszergyár Zártkörüen Müködö Részvénytárasaság · Granted Oct 21, 2008 · Expires Oct 16, 2028

    granted
  24. US 7439027

    Method for modulating process mediated by farnesoid activated receptors

    Ligand Pharmaceuticals Incorporated · Granted Oct 21, 2008 · Expires Oct 16, 2028

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.